The Novitas decision is not all doom and gloom for Pacific Edge

The Novitas decision is not all doom and gloom for Pacific Edge
(Image: Pacific Edge)
Rebecca Howard
News Pacific Edge's Cxbladder tests will no longer be covered by US national health insurance provider Medicare is a “game-changing announcement” but “not all doom and gloom” says Forsyth Barr analysts.On Wednesday, the company confirmed a so-called “local coverage determination” from Novitas – the Medicare administrative contractor – that meant its suite of products does not meet the threshold required for coverage under the US Social Security Act. The stock fell nearly 90% on the news.&...

More Markets

NZ sharemarket claws back to end the week up 0.5%
Markets Market close

NZ sharemarket claws back to end the week up 0.5%

Index rumours drive prices on two shares. 

Graham Skellern 13 Dec 2024
Staff leave Meridian after retail 'reset'
Markets

Staff leave Meridian after retail 'reset'

Expect a very different approach from Meridian in 2025, executive says.

John Anthony 13 Dec 2024
NZX, NZSA want level playing field in climate reporting
Markets

NZX, NZSA want level playing field in climate reporting

Climate reporting liabilities for company directors could soon be eased.

Greg Hurrell 13 Dec 2024
Cannasouth delisting keeps Petterson in charge
Markets

Cannasouth delisting keeps Petterson in charge

Cannasouth major shareholders pushed to end voluntary administration they had called in.

Garth Bray 13 Dec 2024